May 10, 2011 – Patients suffering from blockages of the arteries to the kidneys now have access to a new stenting treatment option with the launch of Cook Medical’s Formula Renal Balloon-Expandable Stent at the Society for Cardiovascular Angioplasty and Intervention (SCAI) 2011 Scientific Sessions. Commercial availability of Formula follows pre-market approval by the U.S. Food and Drug Administration (FDA) earlier this year for use in patients with atherosclerotic disease of the renal arteries.
Formula is approved for treatment of renal artery stenosis following suboptimal percutaneous transluminal renal angioplasty (PTRA) of de novo or restenotic lesions. Available in both over-the-wire or rapid exchange delivery systems (the Formula 418 and Formula 414RX, respectively), the stent will be the lynchpin product of Cook’s new Renal Therapies Program, which encompasses product training and support, clinical trials and a full line of minimally invasive products engineered specifically for the periphery.
For more information: www.cookmedical.com/di